Lung brachytherapy. An overview and current indications.
Although lung cancer remains a difficult and fatal illness for most patients, recent developments provide hope that control and cure are realistic goals. Conventional brachytherapy judiciously used in selected patients may improve local control or relieve severe symptoms. Systemic brachytherapy with radiolabeled antibodies also may prove to be a potentially useful approach. Combined modality therapy will be the most important area of investigation during the next several years.
Hilaris
B S
BS
Department of Radiation Medicine, New York Medical College, Valhalla.
D001918:Brachytherapy / Q000379:methods; D001999:Bronchoscopy; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D007430:Intraoperative Care; D008175:Lung Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic; D013906:Thoracoscopy; D013997:Time Factors; D016896:Treatment Outcome